The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma-Reference-Cited by-同舟云学术

The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma

Published:2007-07 Issue:7 Volume:31 Page:1007-1012
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Dehari Reiko,Kurman Robert J.,Logani Sanjay,Shih Ie-Ming

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference17 articles.

1. Early de novo ovarian carcinoma. A study of fourteen cases;Bell;Cancer,1994

2. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary;Bonome;Cancer Res,2005

3. Geographical variations in TP53 mutational spectrum in ovarian carcinomas;Dansonka-Mieszkowska;Ann Hum Genet,2006

4. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome;Gadducci;Anticancer Res,2006

5. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling;Gilks;Gynecol Oncol,2005

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Retroperitoneal Carcinomas: New Insights into Pathogenesis and Clinical Management in Comparison with Ovarian Carcinomas and Carcinoma of Unknown Primary;Cancers;2023-09-18

2. Low-grade serous ovarian cancer: expert consensus report on the state of the science;International Journal of Gynecologic Cancer;2023-08-17

3. High-Grade Serous Carcinoma;Tumors of the Ovary and Fallopian Tube;2023-08-01

4. Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With Dedifferentiation From a Serous Borderline Tumor;International Journal of Gynecological Pathology;2023-01-11

5. Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience;Diagnostics;2022-12-06